Diacomit

Active Ingredient(s): Stiripentol
FDA Approved: * August 20, 2018
Pharm Company: * BIOCODEX SA
Category: Anticonvulsant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Diacomit Overview

Stiripentol, sold under the brand name Diacomit, is an anticonvulsant medication used for the treatment of epilepsy.[3][4] The most common side effects include loss of appetite, weight loss, insomnia (difficulty sleeping), drowsiness, ataxia (inability to coordinate muscle movements), hypotonia (low muscle strength) and dystonia (muscle disorders).[3] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 6...

Read more Diacomit Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Stiripentol

Recent Diacomit Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Stiripentol
  • Capsule: 250mg, 500mg
  • For Suspension: 250mg/packet, 500mg/packet
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Diacomit: (4 results)

Sorted by National Drug Code
  • 68418-7939 Diacomit 250 mg Oral Capsule by Biocodex Inc.
  • 68418-7940 Diacomit 500 mg Oral Capsule by Biocodex Inc.
  • 68418-7941 Diacomit 1 mg/mg Oral Powder, for Suspension by Biocodex Inc.
  • 68418-7942 Diacomit 1 mg/mg Oral Powder, for Suspension by Biocodex Inc.

Other drugs which contain Stiripentol or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA